XML 24 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value of Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2012
Fair Value of Financial Instruments [Abstract]  
Schedule of fair value assets and liabilities measured on recurring and nonrecurring basis
The following table presents the balances of financial assets and liabilities measured at fair value on a recurring basis during the period (in thousands):

 
 
 
 
 
Fair Value Measurements at June 30, 2012 Using
 
 
 
 
Balance as of June 30,
 
 
Quoted Prices in Active Markets for Identical Assets
 
 
Significant Other Observable Inputs
 
 
Significant Unobservable Inputs
 
Description
 
2012
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Securities available for sale:
 
 
 
 
 
 
 
 
 
 
 
 
   Federal agencies and GSEs
 
$
37,177
 
 
$
-
 
 
$
37,177
 
 
$
-
 
   Mortgage-backed and CMOs
 
 
96,882
 
 
 
-
 
 
 
96,882
 
 
 
-
 
   State and municipal
 
 
192,022
 
 
 
-
 
 
 
192,022
 
 
 
-
 
   Corporate
 
 
8,442
 
 
 
-
 
 
 
8,105
 
 
 
337
 
      Total
 
$
334,523
 
 
$
-
 
 
$
334,186
 
 
$
337
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair Value Measurements at December 31, 2011 Using
 
 
 
 
Balance as of December 31,
 
 
Quoted Prices in Active Markets for Identical Assets
 
 
Significant Other Observable Inputs
 
 
Significant Unobservable Inputs
 
Description
 
2011
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Securities available for sale:
 
 
 
 
 
 
 
 
 
 
 
 
   Federal agencies and GSEs
 
$
32,679
 
 
$
-
 
 
$
32,679
 
 
$
-
 
   Mortgage-backed and CMOs
 
 
103,904
 
 
 
-
 
 
 
103,904
 
 
 
-
 
   State and municipal
 
 
194,405
 
 
 
-
 
 
 
194,405
 
 
 
-
 
   Corporate
 
 
2,378
 
 
 
-
 
 
 
2,054
 
 
 
324
 
      Total
 
$
333,366
 
 
$
-
 
 
$
333,042
 
 
$
324
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

The following table summarizes the Company's assets that were measured at fair value on a nonrecurring basis during the period (in thousands):

      
Fair Value Measurements at June 30, 2012 Using
 
   
 
Balance as of June 30,
  
Quoted Prices in Active Markets for Identical Assets
  
Significant Other Observable Inputs
  
Significant Unobservable Inputs
 
Description
 
2012
  
Level 1
  
Level 2
  
Level 3
 
Assets:
            
Loans held for sale
 $9,215  $-  $9,215  $- 
Impaired loans, net of valuation allowance
  440   -   440   - 
Other real estate owned
  4,731   -   4,731   - 



      
Fair Value Measurements at December 31, 2011 Using
 
   
 
Balance as of December 31,
  
Quoted Prices in Active Markets for Identical Assets
  
Significant Other Observable Inputs
  
Significant Unobservable Inputs
 
Description
 
2011
  
Level 1
  
Level 2
  
Level 3
 
Assets:
            
Loans held for sale
 $6,330  $-  $6,330  $- 
Impaired loans, net of valuation allowance
  1,142   -   1,142   - 
Other real estate owned
  5,353   -   5,353   - 
Schedule of fair value measurements using significant unobservable inputs (Level 3)
   
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
      
Total Realized / Unrealized Gains
         
      
(Losses) Included in
         
   
Balances as of January 1, 2012
 
Net Income
  
Other Comprehensive Income
 
Purchases, Sales, Issuances and Settlements, Net
  
Transfer In (Out) of Level 3
 
Balances as of June 30, 2012
 
Securities available for sale:
                  
                    
 Corporate
 $324  $13  $-  -  $-  $337 
                         
 Total assets
 $324  $13  $-  -  $-  $337 
Schedule of carrying values and estimated fair values of the entity's financial instruments
The carrying values and estimated fair values of the Company's financial instruments as of June 30, 2012 are as follows (in thousands):
 
 
 
 
 
 
Fair Value Measurements at June 30, 2012 using
 
 
 
 
 
 
Quoted Prices in Active Markets for Identical Assets
 
 
Significant Other Observable Inputs
 
 
Significant Unobservable Inputs
 
 
Fair Value
 
 
 
Carrying Value
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
 
Balance
 
Financial Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
28,909
 
 
$
28,909
 
 
$
-
 
 
$
-
 
 
$
28,909
 
Securities avaiable for sale
 
 
334,523
 
 
 
-
 
 
 
334,186
 
 
 
337
 
 
 
334,523
 
Loans held for sale
 
 
9,215
 
 
 
-
 
 
 
9,215
 
 
 
-
 
 
 
9,215
 
Loans, net of allowance
 
 
795,970
 
 
 
-
 
 
 
787,894
 
 
 
-
 
 
 
787,894
 
Bank owned life insurance
 
 
13,273
 
 
 
-
 
 
 
13,273
 
 
 
-
 
 
 
13,273
 
Accrued Iinterest receivable
 
 
5,106
 
 
 
-
 
 
 
5,106
 
 
 
-
 
 
 
5,106
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Deposits
 
$
1,042,485
 
 
$
-
 
 
$
1,020,830
 
 
$
-
 
 
$
1,020,830
 
Repurchase agreements
 
 
46,113
 
 
 
-
 
 
 
46,113
 
 
 
-
 
 
 
46,113
 
Other borrowings
 
 
10,142
 
 
 
-
 
 
 
11,078
 
 
 
-
 
 
 
11,078
 
Trust preferred capital notes
 
 
27,267
 
 
 
-
 
 
 
23,032
 
 
 
-
 
 
 
23,032
 
Accrued interest payable
 
 
758
 
 
 
-
 
 
 
758
 
 
 
-
 
 
 
758
 
The carrying values and estimated fair values of the Company's financial instruments as of December 31, 2011 are as follows (in thousands):


      
Fair Value Measurements at December 31, 2011 using
 
      
Quoted Prices in Active Markets for Identical Assets
  
Significant Other Observable Inputs
  
Significant Unobservable Inputs
  
Fair Value
 
   
Carrying Value
  
Level 1
  
Level 2
  
Level 3
  
Balance
 
Financial Assets:
               
Cash and cash equivalents
 $28,893  $28,893  $-  $-  $28,893 
Securities avaiable for sale
  333,366   -   333,042   324   333,366 
Loans held for sale
  6,330   -   6,330   -   6,330 
Loans, net of allowance
  814,229   -   811,573   -   811,573 
Bank owned life insurance
  13,058   -   13,058   -   13,058 
Accrued Iinterest receivable
  5,091   -   5,091   -   5,091 
                      
Financial Liabilities:
                    
Deposits
 $1,058,754  $-  $1,066,448  $-  $1,066,448 
Repurchase agreements
  45,575   -   45,575   -   45,575 
Other borrowings
  13,206   -   13,064   -   13,064 
Trust preferred capital notes
  27,212   -   27,184   -   27,184 
Accrued interest payable
  857   -   857   -   857